Tag: Aerie

Mergers and Acquisitions

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

August 23, 2022

Via: Biopharma Dive

Alcon has agreed to acquire Aerie Pharmaceuticals for about $770 million, betting its sprawling commercial presence can boost the uptake of the biotechnology company’s two glaucoma drugs. Alcon, the former eyecare business of Swiss pharmaceutical giant Novartis, will pay $15.25 […]